When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVSEF - BioCryst: BCX9930's Hiccup Affects The Entire Company
Novartis Ag Basel Akt
BCRX halted enrollment in 3 trials of BCX9930 following elevated serum creatine in some patients, which indicates kidney impairment.
While Orladeyo is doing very well, BCX9930 was BioCryst's pipeline future.
With strong competition from Novartis and soliris biosims, BCX9930's prospects look bleak, and there are few options left for the company to sustain its valuation.